Evidence of true genotype-phenotype correlation in primary hyperoxaluria type 1

Kidney International

Volumn 77, Issue 5, 2010, Pages 383-385

  Hoppe, Bernd ^a  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE GLYOXYLATE AMINOTRANSFERASE;

ENVIRONMENTAL FACTOR; ETHNICITY; GENE MUTATION; GENETIC HETEROGENEITY; GENOTYPE; HUMAN; KIDNEY FAILURE; NOTE; OXALOSIS 1; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS;

EID: 76749115200     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2009.471     Document Type: Note

References (18)

1. primary hyperoxaluria type 1. Kidney Int 2004; 66: 746-750. 1 4.
2. L o re n zo V, A lv a re z A,T o rre s A et al. Presentation and role of transplantation in adult patients with type 1 primary hyperoxaluria and the I244T mutation: single-center experience. Kidney Int 2006; 70: 1115-1119.
3. Hoppe B, Latta K, von Schnakenburg C et al. Primary hyperoxaluria: the German experience. Am J Nephrol 2005; 25: 276-281.
4. Hoppe B, Beck BB, Milliner DS.The primary hyperoxalurias. Kidney Int 2009; 75: 1264-1271.
5. Williams EL, Acquaviva C, Amoroso A et al. Primary hyperoxaluria type 1: update and additional mutation analysis of the AGXT gene. Hum Mutat 2009; 30: 910-917.
6. Harambat J, Fargue S, Acquaviva C et al. Genotype-phenotype correlation in primary hyperoxaluria type 1: the p.Gly170Arg AGXT mutation is associated with a better outcome. Kidney Int 2010; 77: 443-449.
7. Van Woerden CS, Groothoff JW, Wanders RJ et al. Primary hyperoxaluria type 1 in The Netherlands: prevalence and outcome. Nephrol Dial Transplant 2003; 18: 273-279.
8. Hoppe B, Langman C. A United States survey on diagnosis, treatment and outcome of patients with primary hyperoxaluria. Pediatr Nephrol 2003; 18: 986-991.
9. Kopp N, Leumann E. Changing pattern of primary hyperoxaluria in Switzerland. Nephrol Dial Transplant 1995; 10: 2224-2227.
10. Herrmann G, Krieg T, Weber M et al. Unusual painful sclerotic like plaques on the legs of a patient with late diagnosis of primary hyperoxaluria type I. Br J Dermatol 2004; 151: 1104-1107.
11. Hoppe B, Danpure CJ, Rumsby G et al. A vertical (pseudodominant) pattern of inheritance in the autosomal recessive disease primary hyperoxaluria type I. Lack of relationship between genotype, enzymic phenotype and disease severity. Am J Kidney Dis 1997; 29: 36-44.
12. Danpure CJ. Molecular aetiology of primary hyperoxaluria type 1. Nephron Exp Nephrol 2004; 98: e39-e44.
13. Rumsby G, Williams E, Coulter-Mackie M. Evaluation of mutation screening as a first line test for the diagnosis of the primary hyperoxalurias. Kidney Int 2004; 66: 959-963.
14. Pirulli D, Marangella M, Amoroso A. Primary hyperoxaluria: genotype-phenotype correlation. J Nephrol 2003; 16: 297-309.
15. Monico CG, Rossetti S, Olson JB et al. Pyridoxine effect in type I primary hyperoxaluria is associated with the most common mutant allele. Kidney Int 2005; 67: 1704-1709.
16. Van Woerden CS, Jaap W, Groothoff F et al. Clinical implications of mutation analysis in primary hyperoxaluria type 1. Kidney Int 2004; 66: 746 - 750.
17. Hoppe B, Langman C. A United States survey on diagnosis, treatment, and outcome of primary hyperoxaluria. Pediatr Nephrol 2003; 18: 986-991.
18. Lorenzo V, Alvarez A, Torres A et al. Presentation and role of transplantation in adult patients with type 1 primary hyperoxaluria and the I244T AGXT mutation: single-center experience. Kidney Int 2006; 70: 1115-1119.